EGFR and colorectal carcinoma: This indicates that the activation of SRC kinases upon BRAF ± EGFR targeting regulates the function of β-catenin, a crucial transcription factor in CRC tumorigenesis, which can in turn drive transcriptional reprogramming of cells to sustain and adapt to therapeutic pressure.